Sponsored Links

Novartis Receives FDA Approval For Valturna(R), A Single-Pill Combination Of Valsartan And Aliskiren, To Treat High Blood Pressure PDF Print E-mail
Medical News - Hypertension
The US Food and Drug Administration (FDA) has approved Valturna((R)) (aliskiren and valsartan) tablets, the first and only medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS), an important regulator of blood pressure.

Read more: Hypertension News From Medical News Today